Gene · 51203
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Hub Genes in Comorbidity of Psoriasis and Vitiligo Using Bioinformatics Analysis. | Clin Cosmet Investig Dermatol | 2024 | 39258216 | PubTator, text mining | PubMed |
| Transcriptomic landscape of quiescent and proliferating human corneal stromal fibroblasts. | Exp Eye Res | 2024 | 39243928 | PubTator, text mining | PubMed |
| Esophageal chemical burns as a risk factor for esophageal malignancies: in-silico analyses - experimental research. | Ann Med Surg (Lond) | 2024 | 39239040 | PubTator, text mining | PubMed |
| NUSAP1 promotes gastric cancer radioresistance by inhibiting ubiquitination of ANXA2 and is suppressed by miR-129-5p. | J Cancer Res Clin Oncol | 2024 | 39212774 | PubTator, text mining | PubMed |
| Targeting Osteoblast-Osteoclast Cross-Talk Bone Homeostasis Repair Microcarriers Promotes Intervertebral Fusion in Osteoporotic Rats. | Adv Healthc Mater | 2024 | 39155412 | PubTator, text mining | PubMed |
| Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells. | Med Oncol | 2024 | 39115587 | PubTator, text mining | PubMed |
| Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments. | J Cell Mol Med | 2024 | 39098992 | PubTator, text mining | PubMed |
| The Overexpression of NUSAP1 and GTSE1 Could Predict An Unfavourable Prognosis and Shorter Disease Free Survival in ccRenal Cell Carcinoma. | Asian Pac J Cancer Prev | 2024 | 39068590 | PubTator, text mining | PubMed |
| α-Lactalbumin mRNA-LNP Evokes an Anti-Tumor Effect Combined with Surgery in Triple-Negative Breast Cancer. | Pharmaceutics | 2024 | 39065637 | PubTator, text mining | PubMed |
| Comparative single-cell transcriptional and proteomic atlas of clinical-grade injectable mesenchymal source tissues. | Sci Adv | 2024 | 38996032 | PubTator, text mining | PubMed |
| A prognostic insight of the mRNA vaccine against antibiotic-resistant bacteria. | Ann Med Surg (Lond) | 2024 | 38989193 | PubTator, text mining | PubMed |
| Deciphering the miRNA-mRNA Interaction Landscape between Breast Cancer and Triple-Negative Breast Cancer: An Integrated Bioinformatics Approach. | ACS Omega | 2024 | 38882157 | PubTator, text mining | PubMed |
| Strategies for enhanced gene delivery to the central nervous system. | Nanoscale Adv | 2024 | 38868835 | PubTator, text mining | PubMed |
| Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression. | Redox Biol | 2024 | 38861833 | PubTator, text mining | PubMed |
| Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development. | Pharmaceutics | 2024 | 38794336 | PubTator, text mining | PubMed |
| Modification of Seurat v4 for the Development of a Phase Assignment Tool Able to Distinguish between G2 and Mitotic Cells. | Int J Mol Sci | 2024 | 38731808 | PubTator, text mining | PubMed |
| Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins. | Vaccines (Basel) | 2024 | 38675761 | PubTator, text mining | PubMed |
| Metabolic Signaling in Cancer Metastasis. | Cancer Discov | 2024 | 38592405 | PubTator, text mining | PubMed |
| Immunotherapeutic value of NUSAP1 associated with bladder cancer through a comprehensive analysis of 33 human cancer cases. | Am J Cancer Res | 2024 | 38590423 | PubTator, text mining | PubMed |
| Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells. | Cancer Discov | 2024 | 38587317 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51203/papers?page=7